Related Experiment Video
Updated: Mar 28, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer
1Department of Surgery, Konkuk University School of Medicine, Seoul, Korea.
A new prognostic inflammation score (PIS) combining C-reactive protein (CRP) and neutrophil/lymphocyte ratio (NLR) significantly predicts survival in colorectal cancer (CRC) patients post-surgery.
Area of Science:
- Oncology
- Inflammation Research
- Surgical Pathology
Background:
- Inflammatory markers show promise as prognostic indicators in various cancers.
- Colorectal cancer (CRC) prognosis can be influenced by systemic inflammation.
Purpose of the Study:
- To evaluate common inflammatory markers for prognostic significance in CRC.
- To develop and assess a prognostic inflammation score (PIS) for improved CRC patient outcomes.
Main Methods:
- Retrospective analysis of 265 CRC patients undergoing curative resection.
- Assessment of preoperative serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), and neutrophil/lymphocyte ratio (NLR).
- Uni- and multivariate survival analyses for disease-free survival (DFS) and disease-specific survival (DSS).
Main Results:
- CRP, ESR, and NLR were significant univariate predictors of DFS and DSS.
- CRP and NLR independently predicted DSS and DFS, respectively, in multivariate analysis.
- The combined PIS (CRP + NLR) significantly predicted both DFS and DSS, outperforming individual markers.
Conclusions:
- The PIS, combining CRP and NLR, is a potent independent prognostic variable for CRC patients.
- PIS demonstrates superior prognostic power compared to individual markers like CRP and NLR for survival outcomes.
- This score offers valuable prognostic information regardless of pathological variables in resected CRC.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...